4th Floor, 117 Jermyn Street, SW1Y 6HH London – United Kingdom
Line item in (usd) | 01.01.2020 | 02.01.2020 | 01.01.2021 | 02.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|---|---|
Assets | N/A | 5,960,000,000.00 | 4,171,000,000.00 | 4,159,000,000.00 | 3,807,000,000.00 | 3,267,000,000.00 |
Noncurrent Assets | N/A | 1,012,000,000.00 | 793,000,000.00 | 781,000,000.00 | 713,000,000.00 | 603,000,000.00 |
Property Plant And Equipment | N/A | 398,000,000.00 | 288,000,000.00 | 293,000,000.00 | 269,000,000.00 | 244,000,000.00 |
Goodwill | N/A | 99,000,000.00 | 101,000,000.00 | 101,000,000.00 | 101,000,000.00 | 96,000,000.00 |
Intangible Assets Other Than Goodwill | N/A | 50,000,000.00 | 51,000,000.00 | 34,000,000.00 | 27,000,000.00 | 25,000,000.00 |
Investment Accounted For Using Equity Method | N/A | 38,000,000.00 | 35,000,000.00 | 35,000,000.00 | 34,000,000.00 | 30,000,000.00 |
Deferred Tax Assets | N/A | 50,000,000.00 | 61,000,000.00 | 61,000,000.00 | 18,000,000.00 | 1,000,000.00 |
Other Noncurrent Financial Assets | N/A | 316,000,000.00 | 202,000,000.00 | 202,000,000.00 | 209,000,000.00 | 151,000,000.00 |
Current Assets | N/A | 4,348,000,000.00 | 3,378,000,000.00 | 3,378,000,000.00 | 3,094,000,000.00 | 2,664,000,000.00 |
Inventories | N/A | 17,000,000.00 | 8,000,000.00 | 8,000,000.00 | 23,000,000.00 | 17,000,000.00 |
Trade And Other Current Receivables | N/A | 1,103,000,000.00 | 877,000,000.00 | 877,000,000.00 | 668,000,000.00 | 739,000,000.00 |
Other Current Financial Assets | N/A | 135,000,000.00 | 148,000,000.00 | 148,000,000.00 | 183,000,000.00 | 103,000,000.00 |
Cash and cash equivalents | 914,000,000.00 | N/A | 639,000,000.00 | N/A | 620,000,000.00 | 450,000,000.00 |
Cash | N/A | 1,025,000,000.00 | 684,000,000.00 | 684,000,000.00 | 620,000,000.00 | 450,000,000.00 |
Noncurrent Assets Or Disposal Groups Classified As Held For Sale | N/A | 600,000,000.00 | 0.00 | N/A | 0.00 | N/A |
Equity And Liabilities | N/A | 5,960,000,000.00 | 4,171,000,000.00 | 4,159,000,000.00 | 3,807,000,000.00 | 3,267,000,000.00 |
Equity | 898,000,000.00 | 898,000,000.00 | 398,000,000.00 | 398,000,000.00 | 423,000,000.00 | 112,000,000.00 |
Issued Capital | N/A | 7,000,000.00 | 7,000,000.00 | 7,000,000.00 | 10,000,000.00 | 10,000,000.00 |
Retained Earnings | N/A | 621,000,000.00 | 426,000,000.00 | 414,000,000.00 | 168,000,000.00 | -143,000,000.00 |
Share Premium | N/A | 4,000,000.00 | 4,000,000.00 | 4,000,000.00 | 251,000,000.00 | 251,000,000.00 |
Treasury Shares | N/A | 110,000,000.00 | 88,000,000.00 | 88,000,000.00 | 69,000,000.00 | 56,000,000.00 |
Other Reserves | N/A | 84,000,000.00 | 43,000,000.00 | 43,000,000.00 | 42,000,000.00 | 56,000,000.00 |
Capital Redemption Reserve | N/A | 11,000,000.00 | 11,000,000.00 | 11,000,000.00 | 11,000,000.00 | 11,000,000.00 |
Equity Attributable To Owners Of Parent | N/A | 617,000,000.00 | 403,000,000.00 | 391,000,000.00 | 413,000,000.00 | 129,000,000.00 |
Noncontrolling Interests | N/A | 281,000,000.00 | 7,000,000.00 | 7,000,000.00 | 10,000,000.00 | -17,000,000.00 |
Liabilities | N/A | 5,062,000,000.00 | 3,761,000,000.00 | 3,761,000,000.00 | 3,384,000,000.00 | 3,155,000,000.00 |
Noncurrent Liabilities | N/A | 1,140,000,000.00 | 425,000,000.00 | 425,000,000.00 | 367,000,000.00 | 309,000,000.00 |
Noncurrent Provisions | N/A | 189,000,000.00 | 171,000,000.00 | 171,000,000.00 | 143,000,000.00 | 135,000,000.00 |
Deferred Tax Liabilities | N/A | 37,000,000.00 | 38,000,000.00 | 38,000,000.00 | 29,000,000.00 | 28,000,000.00 |
Other Noncurrent Financial Liabilities | N/A | 315,000,000.00 | 166,000,000.00 | 166,000,000.00 | 195,000,000.00 | 146,000,000.00 |
Longterm Borrowings | N/A | 599,000,000.00 | 50,000,000.00 | 50,000,000.00 | 0.00 | 0.00 |
Current Liabilities | N/A | 3,802,000,000.00 | 3,336,000,000.00 | 3,336,000,000.00 | 3,017,000,000.00 | 2,846,000,000.00 |
Current Provisions | N/A | 47,000,000.00 | 75,000,000.00 | 75,000,000.00 | 81,000,000.00 | 94,000,000.00 |
Trade And Other Current Payables | N/A | 1,075,000,000.00 | 887,000,000.00 | 887,000,000.00 | 1,090,000,000.00 | 865,000,000.00 |
Current Contract Liabilities | N/A | 273,000,000.00 | 120,000,000.00 | 120,000,000.00 | 77,000,000.00 | 136,000,000.00 |
Accruals Classified As Current | N/A | 1,599,000,000.00 | 1,134,000,000.00 | N/A | 780,000,000.00 | N/A |
Other Current Financial Liabilities | N/A | 166,000,000.00 | 179,000,000.00 | 179,000,000.00 | 81,000,000.00 | 114,000,000.00 |
Liabilities Included In Disposal Groups Classified As Held For Sale | N/A | 120,000,000.00 | 0.00 | N/A | 0.00 | N/A |
Current Accrued Expenses And Other Current Liabilities | N/A | N/A | N/A | 1,134,000,000.00 | 798,000,000.00 | 759,000,000.00 |
Current Borrowings And Current Portion Of Noncurrent Borrowings | N/A | 411,000,000.00 | 750,000,000.00 | 750,000,000.00 | 764,000,000.00 | 799,000,000.00 |
Line item in (usd) | 01.01.2020/ 01.01.2021 |
01.01.2021/ 01.01.2022 |
01.01.2022/ 01.01.2023 |
---|---|---|---|
Revenue | 4,081,000,000.00 | 3,038,000,000.00 | 2,591,000,000.00 |
Profit Loss From Operating Activities | -160,000,000.00 | -196,000,000.00 | -217,000,000.00 |
Finance Income | 9,000,000.00 | 15,000,000.00 | 7,000,000.00 |
Finance Costs | 37,000,000.00 | 81,000,000.00 | 116,000,000.00 |
Impairment Loss Impairment Gain And Reversal Of Impairment Loss Determined In Accordance With I F R S9 | 9,000,000.00 | -25,000,000.00 | -23,000,000.00 |
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | 5,000,000.00 | 7,000,000.00 | 5,000,000.00 |
Profit Loss Before Tax | -183,000,000.00 | -255,000,000.00 | -321,000,000.00 |
Income Tax Expense Continuing Operations | 18,000,000.00 | -13,000,000.00 | 16,000,000.00 |
Profit (loss) | -201,000,000.00 | -242,000,000.00 | -337,000,000.00 |
Profit Loss Attributable To Owners Of Parent | -192,000,000.00 | -245,000,000.00 | -310,000,000.00 |
Profit Loss Attributable To Noncontrolling Interests | -9,000,000.00 | 3,000,000.00 | -27,000,000.00 |
Line item in (usd) | 01.01.2020 | 01.01.2021 | 01.01.2022 | 01.01.2023 |
---|---|---|---|---|
Profit (loss) | N/A | -201,000,000.00 | -242,000,000.00 | -337,000,000.00 |
Adjustments For Decrease Increase In Inventories | N/A | 4,000,000.00 | -15,000,000.00 | 7,000,000.00 |
Adjustments For Provisions | N/A | 24,000,000.00 | -2,000,000.00 | 12,000,000.00 |
Adjustments For Unrealised Foreign Exchange Losses Gains | N/A | N/A | 0.00 | 35,000,000.00 |
Adjustments For Sharebased Payments | N/A | 15,000,000.00 | 7,000,000.00 | 6,000,000.00 |
Other Adjustments For Noncash Items | N/A | 1,000,000.00 | -3,000,000.00 | -3,000,000.00 |
Cash Flows From Used In Operations | N/A | 77,000,000.00 | -91,000,000.00 | 21,000,000.00 |
Income Taxes Paid Refund Classified As Operating Activities | N/A | 74,000,000.00 | 42,000,000.00 | 52,000,000.00 |
Cash Flows From Used In Operating Activities | N/A | -30,000,000.00 | -161,000,000.00 | -146,000,000.00 |
Cash Flows From Losing Control Of Subsidiaries Or Other Businesses Classified As Investing Activities | N/A | 31,000,000.00 | 9,000,000.00 | 98,000,000.00 |
Proceeds From Sales Of Property Plant And Equipment Classified As Investing Activities | N/A | 1,000,000.00 | 5,000,000.00 | 1,000,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | N/A | 33,000,000.00 | 43,000,000.00 | 38,000,000.00 |
Purchase Of Intangible Assets Classified As Investing Activities | N/A | 10,000,000.00 | 10,000,000.00 | 8,000,000.00 |
Interest Received Classified As Investing Activities | N/A | 3,000,000.00 | 10,000,000.00 | 6,000,000.00 |
Cash Flows From Used In Investing Activities | N/A | -7,000,000.00 | 38,000,000.00 | 98,000,000.00 |
Proceeds From Issuing Shares | N/A | 0.00 | 250,000,000.00 | 0.00 |
Payments To Acquire Or Redeem Entitys Shares | N/A | 11,000,000.00 | 2,000,000.00 | 0.00 |
Proceeds From Borrowings Classified As Financing Activities | N/A | 870,000,000.00 | 1,484,000,000.00 | 62,000,000.00 |
Repayments Of Borrowings Classified As Financing Activities | N/A | 1,015,000,000.00 | 1,470,000,000.00 | 36,000,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | N/A | 50,000,000.00 | 99,000,000.00 | 54,000,000.00 |
Interest Paid Classified As Financing Activities | N/A | 36,000,000.00 | 36,000,000.00 | 86,000,000.00 |
Cash Flows From Used In Financing Activities | N/A | -242,000,000.00 | 104,000,000.00 | -114,000,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | N/A | -279,000,000.00 | -19,000,000.00 | -162,000,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | N/A | 4,000,000.00 | 0.00 | -8,000,000.00 |
Cash and cash equivalents | 914,000,000.00 | 639,000,000.00 | 620,000,000.00 | 450,000,000.00 |
Please note that some sums might not add up.
Position Holder | Short Interest in Percent | Date |
---|---|---|
Astaris Capital Management LLP | 0.92% | 18.10.23 |
Millennium Capital Partners LLP | 0.60% | 18.10.23 |
GLG Partners LP | 0.73% | 26.07.23 |
Millennium Capital Partners LLP | 0.65% | 28.04.23 |
Qube Research & Technologies Limited | 0.59% | 09.08.23 |
Astaris Capital Management LLP | 1.52% | 06.11.23 |
Helikon Investments Limited | 0.63% | 08.11.23 |
Millennium Capital Partners LLP | 1.20% | 08.11.23 |
Astaris Capital Management LLP | 1.16% | 26.10.23 |
Astaris Capital Management LLP | 1.77% | 16.11.23 |
GLG Partners LP | 0.68% | 16.11.23 |
Helikon Investments Limited | 1.11% | 16.11.23 |
Millennium Capital Partners LLP | 1.30% | 14.11.23 |
Astaris Capital Management LLP | 0.53% | 12.10.23 |
Astaris Capital Management LLP | 1.62% | 22.11.23 |
Helikon Investments Limited | 1.23% | 21.11.23 |
Tages Capital LLP | 0.52% | 23.11.23 |
Whitebox Advisors LLC | 0.54% | 22.11.23 |
GLG Partners LP | 0.82% | 21.08.23 |
Millennium Capital Partners LLP | 0.58% | 18.08.23 |
Qube Research & Technologies Limited | 0.59% | 16.08.23 |
Astaris Capital Management LLP | 1.17% | 28.11.23 |
Helikon Investments Limited | 2.12% | 30.11.23 |
Tages Capital LLP | 0.70% | 30.11.23 |
TFG Asset Management UK LLP | 0.84% | 29.11.23 |
Whitebox Advisors LLC | 0.72% | 28.11.23 |
Total | 24.84% |
GB00B0H2K534
LEI2138004624W8CKCSJ177
Listed Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.